“…Circulating tumor cells (CTCs), which are shed from the primary tumor and spread through the bloodstream to different tissues in the body, lead to the metastasis and spread of cancer. − Compared to traditional biopsy assessments performed on tumor tissue obtained from surgery mostly, “liquid biopsy” of tumors in the peripheral blood of patients has been recognized as a potentially effective means of early cancer diagnosis and screening based on the analysis of biomarkers (i.e., CTCs, cell-free nucleic acids (cfNAs), and extracellular vesicles (EVs)) in the body fluids, in recent years. − However, the rarity of CTCs (only 1–10 CTCs in 10 mL of blood) and the complexity of blood components present major challenges for the efficient isolation of CTCs in blood. , Over the past decade, various strategies have been developed to improve the efficiency of isolating CTCs from patient blood samples, which involve different mechanistic insights, mainly including affinity-based stragtegies, , physical property-based strategies, , and micro/nanofluidics strategies of single-cell profiling. , In comparison, physical property-based isolation has less sensitivity, purity, and specificity due to the similar physical properties of CTCs to some leukocytes. Specific molecular recognition between receptors and ligands plays a huge role in cell capture .…”